» Articles » PMID: 20397079

Re-framing Microbicide Acceptability: Findings from the MDP301 Trial

Overview
Journal Cult Health Sex
Publisher Informa Healthcare
Specialty Social Sciences
Date 2010 Apr 17
PMID 20397079
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Microbicides are most usually conceptualised within a disease prevention framework and studies usually define acceptability in terms of product characteristics, willingness to use and risk reduction. This starting point has led to assumptions about microbicides which, rather than being challenged by empirical studies, have tended to foreclose the data and subsequent conceptual models. Few studies take an emic ('insider') perspective or attempt to understand how microbicides fit into the broader context of women's and men's everyday lives. As part of the integrated social science component of the MDP301 Phase III microbicide trial, in-depth interviews were conducted with female trial participants in South Africa, Zambia, Tanzania and Uganda. Women's experiences of the gel challenge several assumptions that have commonly been reiterated about microbicides. Our analysis suggests that current definitions and conceptual frameworks do not adequately account for the range of meanings that women attribute to gel. Even within the context of a clinical trial, it is possible to obtain a richer, ethnographic and cross-cultural concept of acceptability based on women's practice and emic interpretations. We now need to move beyond limited notions of acceptability and consider how microbicides fit into a more holistic picture of women's and men's sexuality and sexual health.

Citing Articles

House modifications as a malaria control tool: how does local context shape participants' experience and interpretation in Uganda?.

Kayendeke M, Nabirye C, Nayiga S, Westercamp N, Gonahasa S, Katureebe A Malar J. 2023; 22(1):244.

PMID: 37626312 PMC: 10463640. DOI: 10.1186/s12936-023-04669-1.


Female and male partner perspectives on placebo Multipurpose Prevention Technologies (MPTs) used by women in the TRIO study in South Africa and Kenya.

Wagner L, Minnis A, Shea J, Agot K, Ahmed K, van der Straten A PLoS One. 2022; 17(5):e0265303.

PMID: 35551318 PMC: 9097999. DOI: 10.1371/journal.pone.0265303.


Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya.

Rousseau E, Katz A, ORourke S, Bekker L, Delany-Moretlwe S, Bukusi E PLoS One. 2021; 16(10):e0258542.

PMID: 34648589 PMC: 8516266. DOI: 10.1371/journal.pone.0258542.


Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.

Miller L, Morar N, Kapiga S, Ramjee G, Hayes R J Acquir Immune Defic Syndr. 2020; 85(4):458-465.

PMID: 33136745 PMC: 7993915. DOI: 10.1097/QAI.0000000000002463.


Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.

Eakle R, Weatherburn P, Bourne A J Int AIDS Soc. 2019; 22 Suppl 4:e25306.

PMID: 31328429 PMC: 6643067. DOI: 10.1002/jia2.25306.